FORM OF VOTING AGREEMENTVoting Agreement • January 19th, 2011 • Oxigene Inc • Biological products, (no disgnostic substances) • Delaware
VOTING AGREEMENT, dated as of January __, 2011 (this “Agreement”), by and among OXiGENE, Inc., a Delaware corporation with offices located at 701 Gateway Blvd, Suite 210, South San Francisco, CA 94080 (the “Company”) and [Symphony ViDA Holdings LLC, a Delaware limited liability company with offices located at 875 Third Avenue, 18th Floor, New York, NY 10022] (the “Stockholder”).
FORM OF WARRANT EXCHANGE AGREEMENTWarrant Exchange Agreement • January 19th, 2011 • Oxigene Inc • Biological products, (no disgnostic substances)
THIS WARRANT EXCHANGE AGREEMENT (the “Agreement”) is dated as of January 18, 2011, by and between OXiGENE, Inc., a Delaware corporation with offices located at 701 Gateway Blvd, Suite 210, South San Francisco, CA 94080 (the “Company”), and _______________ (the “Investor”).
AMENDMENT NO. 4 TO STOCKHOLDER RIGHTS AGREEMENTStockholder Rights Agreement • January 19th, 2011 • Oxigene Inc • Biological products, (no disgnostic substances) • Delaware
This Amendment No. 4 to Stockholder Rights Agreement (the “Amendment”), dated as of January 18, 2011, by and between OXiGENE, Inc., a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, LLC (the “Rights Agent”), amends that certain Stockholder Rights Agreement, dated as of March 24, 2005, as amended as of October 1, 2008, October 14, 2009 and March 10, 2010, between the Company and the Rights Agent (as so amended, the “Agreement”).
